Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis – New England Journal of Medicine Commentary on Twitter Original Article: Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (IMPALA Trial) #ERScongress — NEJM (@NEJM) September 7, 2020
The post #ERScongress – [Abstract Only] Inhaled Molgramostim therapy in autoimmune pulmonary alveolar proteinosis appeared first on Links Medicus.
Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19 – American Journal of Physical Medicine & Rehabilitation
The post Review: Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19 appeared first on Links Medicus.
“When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination – New England Journal of Medicine Commentary on Twitter People inquiring about Covid-19 vaccines often want to know when the public can be confident that available vaccines are safe and effective, when a vaccine will be available to people like them, and […]
The post Perspective: “When will WE have a vaccine?” — understanding questions and answers about Covid-19 vaccination appeared first on Links Medicus.
Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine – New England Journal of Medicine Commentary on Twitter Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses […]
The post Opinion: “Facial masking for Covid-19 — potential for “variolation” as we await a vaccine” appeared first on Links Medicus.
Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial) – medRxiv Commentary on Twitter Convalescent Plasma Randomized Controlled Trial (PLACID Trial) in the Management of Moderate #COVID19 (pre-print) ? “not associated with reduction in mortality or progression to severe COVID-19” Link: https://t.co/2ZXnfemsas@GermHunterMD […]
The post [Preprint] Randomized trial: Convalescent plasma not associated with improved outcomes in Covid-19 appeared first on Links Medicus.
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K. – STAT Commentary on Twitter BREAKING: AstraZeneca's #Covid19 vaccine trials have been paused as the company investigates a serious adverse event the occurred in the UK. Not clear if the unexplained illness is linked to the vaccine, […]
The post AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K. appeared first on Links Medicus.
Testing for SARS-CoV-2 antibodies – The BMJ Commentary on Twitter #BMJInfographic Try out this new interactive calculator for interpreting covid-19 antibody test results @will_s_t https://t.co/t0Ha5zMlg1 pic.twitter.com/TAjVLog3A1 — The BMJ (@bmj_latest) September 8, 2020
The post Interactive calculator for interpreting Covid-19 antibody test results appeared first on Links Medicus.
Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial – JAMA (free for a limited period) Commentary: Relief for people who struggle with CPAP masks – Flinders University Author interview: Treating Obstructive Sleep […]
The post Randomized trial: Upper airway surgery vs. medical management for patients with moderate or severe obstructive sleep apnea who failed conventional treatment appeared first on Links Medicus.
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis – Journal of General Internal Medicine Related Meta-analysis: Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis – Arthritis & Rheumatology
The post Meta-analysis: Chloroquine and Hydroxychloroquine do not improve outcomes in COVID-19 appeared first on Links Medicus.
COVID-19 is, in the end, an endothelial disease – European Heart Journal Commentary on Twitter COVID as an infectious disease of the “endothelium”, the lining of blood vessels, transmitted pre-sympyomatically. Explains the sepsis syndrome; explains the clotting/bleeding; explains the kidney failure. What a nasty, nasty disease.https://t.co/5hlfL5Iik9 — David Fisman (@DFisman) September 7, 2020
The post COVID-19 is, in the end, an endothelial disease appeared first on Links Medicus.